Human Stem Cells Institute OJSC (HSCI) is a Russian public biotech company founded in 2003.

HSCI is engaged in R&D as well as commercialization and marketing of innovative drugs and high-tech medical services.

The Company strives to foster a new culture of medical care linked to the concepts of personalized and preventive medicine.

Today, HSCI’s projects encompass the five main focus areas of modern biomedical technologies:
• regenerative medicine
• gene therapy
• medical genetics
• bio-insurance
• biopharmaceutics (within the international SynBio project).